A newly discovered method of detecting early-stage Alzheimer’s disease through a simple blood test has shown promising results in identifying biomarkers linked to the condition. Researchers highlight that the test could enable earlier intervention and potentially slow the progression of cognitive decline. The approach focuses on specific protein patterns that differentiate Alzheimer’s from other neurological disorders. Early detection remains a critical challenge in managing the disease, and this development could offer a non-invasive alternative to costly and invasive diagnostic procedures.